Serina Therapeutics SER Cash Flow Statement (2017-2026)

NYSE SER
$2.43 -0.14 (-5.36%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Serina Therapeutics Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Serina Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 34 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-2.48M-1.96M-2.26M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M-6.41M-6.99M
Share-based CompensationStock Comp.
3.38M0.27M0.26M0.24M3.27M3.26M0.11M5.14M5.14M5.11M36.40M1.65M0.96M0.89M1.00M0.95M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Investment SecuritiesGains Investment
0.09M0.17M-0.04M0.01M-0.17M-0.29M-0.60M-0.02M-5.58M-9.30M-6.70M-2.80M-0.99M1.00M-1.04M-3.20M
Cash from OperationsCash from Ops.
-1.69M-1.88M-1.65M-1.64M-1.75M-1.24M-1.32M-0.71M-0.86M-1.02M0.12M-1.58M-8.01M-2.96M-4.59M-4.32M-3.75M-3.85M-6.08M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Amortization of Deferred ChargesAmort. Deferred Charges
0.27M0.28M0.29M0.54M0.81M0.87M0.92M1.06M0.92M-1.98M0.02M0.31M0.01M0.01M0.06M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.02M0.05M0.01M0.03M0.06M0.06M0.06M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.04M0.01M0.00M-0.03M0.01M-0.01M0.00M0.00M-0.00M0.06M-0.01M
Change in Account PayablesChange Payables
-0.31M-0.31M-0.33M-0.33M-0.33M-0.35M-0.36M1.23M-0.13M0.24M-1.45M0.49M-0.95M0.44M0.52M1.04M-0.81M
Change in Accured ExpensesChange Accured Exp.
0.10M-0.38M-0.15M0.21M-0.41M0.11M0.24M0.23M-0.05M-0.25M-0.08M0.40M-0.60M0.33M0.27M-0.39M0.76M-0.67M0.07M
Other Working Capital ChangesOther WC Changes
Investing Activities
Capital ExpendituresCapex
0.12M0.07M0.01M0.00M0.01M0.05M0.01M
Divestments
Cash from Investing ActivitiesCash from Investing
0.25M-10.00M9.69M-0.12M-0.07M-0.01M-0.00M-0.01M-0.05M-0.01M
Financing Activities
Other financing activitiesOther financing
-2.25M0.01M0.00M4.98M0.00M0.00M0.01M0.01M
Cash from Financing ActivitiesCash from Financing
1.25M2.00M1.50M1.50M2.00M1.00M1.50M10.09M-0.01M0.00M-0.01M2.73M5.37M0.09M5.03M4.92M5.57M6.44M0.48M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.57M0.01M0.01M0.07M0.64M
Net Equity Issued and RepurchasedNet Equity Issued
4.92M0.02M
Additional items
Exchange Rate EffectFX Effect
-0.00M-0.01M
Change in Cash
-0.19M0.12M-0.15M-0.14M0.25M-0.24M0.18M9.38M-1.19M-1.14M0.04M1.14M-2.64M-2.88M0.44M0.59M1.77M2.58M-5.56M
Free Cash FlowFCF
-1.69M-1.88M-1.65M-1.64M-1.75M-1.24M-1.32M-0.71M-0.86M-1.14M0.05M-1.59M-8.01M-2.96M-4.59M-4.32M-3.80M-3.86M-6.08M
Net Cash FlowNCF
-0.19M0.12M-0.15M-0.14M0.25M-0.24M0.18M-0.62M8.81M-1.14M0.04M1.14M-2.64M-2.88M0.44M0.59M1.77M2.58M-5.60M